Home › Funds › PSP Research LLC › DFTX
PSP Research LLC position in DFTX
DEFINIUM THERAPEUTICS INC · Health Care
PSP Research LLC reported holding 6,500 shares of DFTX (DEFINIUM THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$247K, representing 0.17% of its reported portfolio and ranking #20 among its reported holdings. PSP Research LLC has disclosed DFTX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR
How PSP Research LLC's DFTX position evolved
PSP Research LLC first disclosed a stake in DFTX in Q1 2026 at 34,800 shares (US$658K). Across 3 filings, PSP Research LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 6,500 shares valued at US$247K — a reduction of -3,500 shares quarter over quarter.. Notable position changes include a 71% trim in Q2 2026 (shares fell 19% over the following quarter), a 35% trim in Q3 2026 (shares fell 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 34.80K | $657.72K | New |
| Q2 2026 | 10.00K | $470.40K | Reduce |
| Q3 2026 | 6.50K | $247.39K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DFTX and 13F data
DFTX (DEFINIUM THERAPEUTICS INC) is a Health Care company. 190 other funds we track also report a position in DFTX — the largest reported positions include Avoro Capital Advisors LLC (US$338.2M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$322.0M), Octagon Capital Advisors LP (US$138.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DFTX
- Avoro Capital Advisors LLC 7.19M sh · $338.17M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 6.85M sh · $322.00M · Q2 2026
- Octagon Capital Advisors LP 2.95M sh · $138.77M · Q2 2026
- Deep Track Capital, LP 2.75M sh · $129.36M · Q2 2026
- Commodore Capital LP 2.00M sh · $94.08M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 1.50M sh · $70.56M · Q2 2026
- Siren, L.L.C. 1.42M sh · $66.77M · Q2 2026
- Boxer Capital Management, LLC 998.50K sh · $46.97M · Q2 2026
- AWM Investment Company, Inc. 784.80K sh · $36.92M · Q2 2026
- ArrowMark Colorado Holdings LLC 564.07K sh · $26.53M · Q2 2026
- Catalio Capital Management, LP 562.67K sh · $26.47M · Q2 2026
- Integral Health Asset Management, LLC 550.00K sh · $25.87M · Q2 2026
More on PSP Research LLC
FAQ
How long has PSP Research LLC held DFTX?
PSP Research LLC has disclosed DFTX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is PSP Research LLC's current position in DFTX?
As of Q3 2026, PSP Research LLC holds 6.50K shares of DFTX (DEFINIUM THERAPEUTICS INC), valued at $247.39K, representing 0.17% of its reported portfolio and ranking #20.
Has PSP Research LLC been buying or selling DFTX?
In the latest 13F filing (Q3 2026), PSP Research LLC reduced its position in DFTX.
Which other funds hold DFTX?
Other major institutional holders of DFTX include Avoro Capital Advisors LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, Octagon Capital Advisors LP, among 190 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.